ATE247462T1 - Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist - Google Patents
Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden istInfo
- Publication number
- ATE247462T1 ATE247462T1 AT99952021T AT99952021T ATE247462T1 AT E247462 T1 ATE247462 T1 AT E247462T1 AT 99952021 T AT99952021 T AT 99952021T AT 99952021 T AT99952021 T AT 99952021T AT E247462 T1 ATE247462 T1 AT E247462T1
- Authority
- AT
- Austria
- Prior art keywords
- valproate
- metformin
- weight gain
- gain associated
- psychotropic drugs
- Prior art date
Links
- AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 title abstract 4
- 229940102566 valproate Drugs 0.000 title abstract 4
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 title abstract 3
- 229960003105 metformin Drugs 0.000 title abstract 3
- 230000004584 weight gain Effects 0.000 title abstract 2
- 235000019786 weight gain Nutrition 0.000 title abstract 2
- 229940001470 psychoactive drug Drugs 0.000 title 1
- 239000004089 psychotropic agent Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 229940123208 Biguanide Drugs 0.000 abstract 1
- -1 biguanide compound Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10439498P | 1998-10-15 | 1998-10-15 | |
| US09/416,330 US6194466B1 (en) | 1998-10-15 | 1999-10-12 | Use of metformin to counteract weight gain associated with valproate and other psychotropic medications |
| PCT/US1999/024262 WO2000021522A1 (en) | 1998-10-15 | 1999-10-15 | Use of metformin to counteract weight gain associated with valproate and other psychotropic medications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE247462T1 true ATE247462T1 (de) | 2003-09-15 |
Family
ID=26801492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99952021T ATE247462T1 (de) | 1998-10-15 | 1999-10-15 | Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6194466B1 (de) |
| EP (1) | EP1121110B1 (de) |
| AT (1) | ATE247462T1 (de) |
| AU (1) | AU6432899A (de) |
| DE (1) | DE69910600T2 (de) |
| WO (1) | WO2000021522A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4167742B2 (ja) * | 1998-01-23 | 2008-10-22 | 中央発條株式会社 | 押し引きコントロールケーブル |
| US20050171088A1 (en) * | 2004-01-30 | 2005-08-04 | Astrazeneca Ab | Treatment of psychoses with dibenzothiazepine antipsychotic |
| US20060246131A1 (en) * | 2005-04-28 | 2006-11-02 | Cottlingham Elizabeth M | Use of metformin to counteract weight gain associated with psychotropic medications |
| WO2008090534A1 (en) * | 2007-01-26 | 2008-07-31 | Berand Limited | Methods and compositions for inhibition of excessive weight gain, reduction of inappropriate eating behaviours and inhibition of binge eating for the treatment of obesity |
| WO2017023833A1 (en) | 2015-08-01 | 2017-02-09 | Petti Stephen J | Compositions and methods for combination pharmacological treatments to induce a prolonged, mild decrease in core body temperature |
| WO2020037326A1 (en) * | 2018-08-17 | 2020-02-20 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by downregulating foxo |
| CA3109647A1 (en) | 2018-08-17 | 2020-02-20 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by upregulating jag-1 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4432757A1 (de) * | 1994-09-14 | 1996-03-21 | Boehringer Mannheim Gmbh | Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung |
-
1999
- 1999-10-12 US US09/416,330 patent/US6194466B1/en not_active Expired - Lifetime
- 1999-10-15 DE DE69910600T patent/DE69910600T2/de not_active Expired - Lifetime
- 1999-10-15 AU AU64328/99A patent/AU6432899A/en not_active Abandoned
- 1999-10-15 WO PCT/US1999/024262 patent/WO2000021522A1/en not_active Ceased
- 1999-10-15 EP EP99952021A patent/EP1121110B1/de not_active Expired - Lifetime
- 1999-10-15 AT AT99952021T patent/ATE247462T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69910600T2 (de) | 2004-06-24 |
| AU6432899A (en) | 2000-05-01 |
| DE69910600D1 (de) | 2003-09-25 |
| EP1121110A1 (de) | 2001-08-08 |
| WO2000021522A1 (en) | 2000-04-20 |
| EP1121110B1 (de) | 2003-08-20 |
| US6194466B1 (en) | 2001-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20043269B (en) | Purine Derivatives, Method for Their Production and Composition Containing the Same | |
| GEP20063799B (en) | Tropane derivatives useful in therapy | |
| MY119403A (en) | Novel compounds with analgesic effect. | |
| TR200102962T2 (tr) | Yeni tedavi metodu. | |
| MY132705A (en) | Novel compounds with analgesic effect | |
| PT740650E (pt) | Co-farmacos como um metodo de administracao controlada de farmacos | |
| NZ540385A (en) | Use of 1-oxo-2-(2, 6-dioxopiperidin-3-yl)-4-methylisoindoline in the manufacture of a medicamnent for treatment of brain cancer | |
| AU2506388A (en) | Azelastine-containing medicaments for application in the nose and/or at the eye | |
| NO307495B1 (no) | Anvendelse av riluzol ved fremstilling av medikamenter for behandling av Parkinsons sykdom og Parkinsonske syndromer | |
| DE69531098D1 (de) | Piperidine und pyrrolidine | |
| BR0013065A (pt) | Método e composto para tratar de uma doença associada com recrutamento e/ ou ativação aberrante de leucócitos | |
| DE60143911D1 (de) | Antitumorzusammensetzungen welche ecteinascidin 743 enthalten | |
| BG106171A (en) | Compositions and uses of et743 for treating cancer | |
| NZ507203A (en) | Use of dexmedetomidine for ICU sedation | |
| ATE99172T1 (de) | Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung. | |
| ATE247462T1 (de) | Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist | |
| NO943288L (no) | Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer | |
| ATE126061T1 (de) | Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum. | |
| BR0009380A (pt) | Tratamento de câncer melhorado comtemozolomida | |
| AU3401093A (en) | Therapeutic agent for threatened abortion | |
| TR199801184T2 (xx) | Analjezik tesirli yeni bile�ikler. | |
| JPS6483020A (en) | Medicinal composition for preventing or treating aids | |
| RU96115219A (ru) | Способ лечения больных сахарным диабетом | |
| YU25202A (sh) | Supstituisani piroli kao antiproliferativna sredstva za lečenje kancera | |
| ES2053683T3 (es) | Forma de medicamento de aplicacion oral para el tratamiento de la hipertension una vez al dia con hidrocloruro de diltiazem. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |